C63.8 — Malignant neoplasm of overlapping sites of male genital organs
C63.8 is a billable, specific ICD-10-CM code for malignant neoplasm of overlapping sites of male genital organs. It is valid for submission on a claim.
Inclusion terms
Alternative wordings a physician may use in the chart for this same code.
- Primary malignant neoplasm of two or more contiguous sites of male genital organs whose point of origin cannot be determined
Risk adjustment
C63.8 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 23 Prostate, Breast, and Other Cancers and Tumors0.186 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.
Medicare coverage
C63.8 is named in 57 Medicare coverage policies — 57 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
- A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
Related codes at this level
Codes that share C63. If C63.8 is not quite right, the correct code is usually one of these.
Questions about C63.8
- Is C63.8 a billable ICD-10-CM code?
- Yes. C63.8 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C63.8 sit in the tabular list?
- Neoplasms (C00-D49), in the block Malignant neoplasms of male genital organs (C60-C63).